Albarico, Roselle E.

HRN: 02-63-69  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/20/2026
CEFUROXIME 1.5GM (VIAL)
01/20/2026
01/21/2026
IV
1.5gms
Q8hrs X 3 Doses
S/P Primary LSTCS With Intra CS IUD Insertion
Checking Initial Appropriateness 
01/21/2026
CEFUROXIME 500MG (TAB)
01/21/2026
01/28/2026
ORAL
500mg
BID
S/P CS
Checking Initial Appropriateness 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: